Author:
Xia Shenglong,Liu Zimo,Cai Jieru,Ren Huiming,Li Qi,Zhang Hongfang,Yue Jing,Zhou Quan,Zhou Tianhua,Wang Liangjing,Liu Xiangrui,Zhou Xuefei
Funder
Higher Education Discipline Innovation Project
National Natural Science Foundation of China
Reference57 articles.
1. Liver fibrosis: therapeutic targets and advances in drug therapy;Tan;Front Cell Dev Biol.,2021
2. Determinants of fibrosis progression and regression in NASH;Schuppan;J. Hepatol.,2018
3. Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review;Zhou;J. Drug Target.,2022
4. Progress in drug delivery system for fibrosis therapy, Asian;Xing;J. Pharm. Sci.,2021
5. Antihepatic fibrosis drugs in clinical trials;Guo;J Clin Transl Hepatol.,2020
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献